Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples